BioMarin Pharmaceutical Inc. (0HNC.L) Stock Price
$57.56 0.2%
to add to portfolio
AI Score
-
Alternative
7 -
Fundamental
8 -
Technical
5
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on BioMarin Pharmaceutical Inc., AI stock picks, stock alerts and much more.
0HNC.L AI Stock Analysis
AI stock analysis for 0HNC.L is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like BioMarin Pharmaceutical Inc. (0HNC.L) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
BioMarin Pharmaceutical Inc. (0HNC.L) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of BioMarin Pharmaceutical Inc. (0HNC.L), currently trading at $57.56, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About 0HNC.L
-
BioMarin Pharmaceutical Inc.
-
Symbol
0HNC.L
-
Market
LSE
-
Industry
Medical - Pharmaceuticals
-
Market Cap
11.1B
Similar Stocks
 |
Vertex Pharmaceuticals Incorporated 0QZU.L |
$390.4 1.1% |
7 |
 |
Neurocrine Biosciences 0K6R.L |
$133.6 0.9% |
7 |
 |
Emergent BioSolutions Inc. 0IGA.L |
$8.88 1% |
4 |
 |
Abeona Therapeutics Inc. 0H7R.L |
$6.93 3.9% |
5 |
 |
Walgreens Boots Alliance 0LSZ.L |
$11.99 0.6% |
5 |
News
0HNC.L Alternative Data
Web Traffic
BioMarin Pharmaceutical Inc. receives an estimated 74539 monthly visitors to biomarin.com.
-
Web Traffic
74539
-
Change from Previous Month
2.4%
-
3 Month Change
0.8%
-
YoY Change
0.8%
Twitter Followers
BioMarin Pharmaceutical Inc. has 733 Twitter Followers on its main Twitter (also known as X) account, which is up by 2.8% over the last month.
-
Twitter Followers
733
-
Daily Change
0%
-
1 Month Change
2.8%
-
3 Month Change
5.6%
-
YoY Change
5.6%
TikTok Followers
BioMarin Pharmaceutical Inc. has 20 TikTok Followers on its main TikTok account, up by 11.1% over the last month.
-
TikTok Followers
20
-
Daily Change
0%
-
1 Month Change
11.1%
-
3 Month Change
25%
Facebook Engagement
BioMarin Pharmaceutical Inc. has engaged 1,691 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
1691
-
Daily Change
33.4%
-
1 Month Change
6163%
-
3 Month Change
701.4%
-
YoY Change
701.4%
Instagram Followers
BioMarin Pharmaceutical Inc. has 5,767 Instagram Followers on its main Instagram account, up by 1.6% over the last month.
-
Instagram Followers
5767
-
Daily Change
0.1%
-
1 Month Change
1.6%
-
3 Month Change
4.9%
-
YoY Change
4.9%
Youtube Subscribers
BioMarin Pharmaceutical Inc. has 1,950 subscribers on its main Youtube channel.
-
Youtube Subscribers
1950
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
1.6%
Job Postings
BioMarin Pharmaceutical Inc. has an estimated 117 open job postings, which is down -4.9% over the last month.
-
Job Postings
117
-
Daily Change
0.8%
-
1 Month Change
4.9%
-
3 Month Change
12.7%
-
YoY Change
12.7%
Reddit Mentions
BioMarin Pharmaceutical Inc. has been mentioned an estimated 1 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
1
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
LinkedIn Followers
198,038 are following BioMarin Pharmaceutical Inc. on LinkedIn, up by 1.4% over the last month.
-
LinkedIn Followers
198038
-
Daily Change
1.4%
-
1 Month Change
1.4%
-
3 Month Change
4.7%
-
YoY Change
4.7%
LinkedIn Employees
According to LinkedIn, BioMarin Pharmaceutical Inc. has 3,125 employees, up by 0.3% over the last month.
-
LinkedIn Employees
3125
-
Daily Change
0.3%
-
1 Month Change
0.3%
-
3 Month Change
0.7%
-
YoY Change
0.7%
Business Outlook
According to employee reviews, the business outlook among employees at BioMarin Pharmaceutical Inc. is 34 out of 100 (bearish).
-
Business Outlook
34
-
Change from Previous Month
0%
-
3 Month Change
10.5%
-
YoY Change
10.5%
News Mentions
BioMarin Pharmaceutical Inc. was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
0HNC.L Financials
0HNC.L Key Metrics
-
Total Revenue
$745.1M
-
Net Income
$185.7M
-
Earnings per Share
$0.97
-
Free cash flow
$157.6M
-
EBITDA
$223.9M
-
EBITDA Ratio
0.300469
-
Total Assets
$7.1B
0HNC.L 2-year Revenue & Income
0HNC.L 2-year Free Cash Flow
0HNC.L Technicals
0HNC.L SMA
0HNC.L RSI
FAQ
What's the current price of BioMarin Pharmaceutical Inc. (0HNC.L) Stock?
The price of an BioMarin Pharmaceutical Inc. (0HNC.L) share is $57.56.
What's the market cap of BioMarin Pharmaceutical Inc.?
The current market cap of BioMarin Pharmaceutical Inc. is 11.1B.
Should I buy or sell 0HNC.L?
Multiple alternative data signals suggest that BioMarin Pharmaceutical Inc. stock could offer a buying opportunity at its current level, with a reasonable expectation for positive performance in the mid term.
Is BioMarin Pharmaceutical Inc. a good investment?
Based on an in-depth analysis that encompasses fundamentals, technical analysis, and alternative data insights, it appears to be a favorable time to consider investing in BioMarin Pharmaceutical Inc. stock. The bullish indicators suggest that BioMarin Pharmaceutical Inc.'s growth prospects and market position may lead to a positive performance in the foreseeable future.
Is now a good time to buy BioMarin Pharmaceutical Inc. (0HNC.L) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, it could be a favorable time to consider buying BioMarin Pharmaceutical Inc. stock, given the bullish outlook.
What are some stocks similar to BioMarin Pharmaceutical Inc. (0HNC.L) that investors often compare it to?
BioMarin Pharmaceutical Inc. (0HNC.L) is often compared to similar stocks such as Vertex Pharmaceuticals Incorporated, Neurocrine Biosciences, Emergent BioSolutions Inc., Abeona Therapeutics Inc. and Walgreens Boots Alliance.
What is the forecast for BioMarin Pharmaceutical Inc.'s stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast BioMarin Pharmaceutical Inc.'s stock price to be around $61.92 in 2026. Starting from the current price of $57.56, this represents a 7.6% change in price, indicating a bullish outlook for the stock.
How to buy BioMarin Pharmaceutical Inc. (0HNC.L) Stock?
BioMarin Pharmaceutical Inc. stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy BioMarin Pharmaceutical Inc. shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.